By Hanna Vioque ( April 30, 2026, 7:31 PM BST) -- Novo Nordisk has obtained an inadvertent win against a rival's patent for a method of modifying antibodies in the blood, after the Japanese pharmaceutical company told European appellate officials that it no longer approved of the claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.